HAL Allergy at a glance
Improving the quality of life with innovative causal allergy treatments for more than 60 years
HAL Allergy is one of the European top players in the field of allergy immunotherapy and has an internationally leading role in the production of modified allergen extracts for both, therapeutic and diagnostic purposes. We focus on the development, production and distribution of allergen immunotherapies for the treatment and prevention of allergic diseases.
Since its foundation 1959, HAL Allergy grew to a well-established player in the AIT market with a highly competitive portfolio offering subcutaneous (SCIT) and sublingual (SLIT) products for pollen, house dust mites and insect venoms. Our GMP certified and state-of-the-art production facility is located in the Bio Science Park in Leiden, The Netherlands.